Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells

Int J Mol Sci. 2020 Apr 30;21(9):3166. doi: 10.3390/ijms21093166.

Abstract

It is known that single or isolated tumor cells enter cancer patients' circulatory systems. These circulating tumor cells (CTCs) are thought to be an effective tool for diagnosing cancer malignancy. However, handling CTC samples and evaluating CTC sequence analysis results are challenging. Recently, the convolutional neural network (CNN) model, a type of deep learning model, has been increasingly adopted for medical image analyses. However, it is controversial whether cell characteristics can be identified at the single-cell level by using machine learning methods. This study intends to verify whether an AI system could classify the sensitivity of anticancer drugs, based on cell morphology during culture. We constructed a CNN based on the VGG16 model that could predict the efficiency of antitumor drugs at the single-cell level. The machine learning revealed that our model could identify the effects of antitumor drugs with ~0.80 accuracies. Our results show that, in the future, realizing precision medicine to identify effective antitumor drugs for individual patients may be possible by extracting CTCs from blood and performing classification by using an AI system.

Keywords: chemotherapy; convolutional neural network; deep learning; resistance; single cancer cell.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Cells, Cultured
  • Deep Learning*
  • Drug Resistance, Neoplasm*
  • Humans
  • Machine Learning
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neural Networks, Computer*
  • Precision Medicine / methods
  • Single-Cell Analysis

Substances

  • Antineoplastic Agents